Marksans Pharma Limited — Credit Ratings, 08-10-2025: Credit Rating- Others

CARE Ratings upgraded Marksans Pharma's long-term bank facilities (₹135 Cr) to CARE AA-; Stable from CARE A+; Positive. This reflects consistent operational performance, 21% revenue growth in FY25, healthy profitability, and an enhanced business profile from completed capex and a strong product pipeline. Short-term facilities (₹120.75 Cr) were reaffirmed at CARE A1+.